Cancer Survival Rate Exhibit Cited in Investment Strategy Report

Cancer Survival Rate Exhibit Cited in Investment Strategy Report The passage only presents statistical data on breast and prostate cancer survival rates and commentary on measurement methodology. It contains no allegations, financial flows, or connections to high‑profile individuals or agencies, offering no actionable investigative leads. Key insights: Shows 10‑year survival rates for UK breast and prostate cancer from 1971 to 2011.; Mentions potential mismeasurement and evolving productivity metrics.; References Wall Street Journal article on slowing gains in science and medicine.